NMR-based lipidomic analysis of blood lipoproteins differentiates the progression of coronary heart disease

Journal of Proteome Research

Volumn 13, Issue 5, 2014, Pages 2585-2598

  Kostara, Christina E ^a   Papathanasiou, Athanasios ^a   Psychogios, Nikolaos ^b   Cung, Manh Thong ^c   Elisaf, Moses S ^a   Goudevenos, John ^a   Bairaktari, Eleni T ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b Process Development Shire   (United States)

^c LAB DE CHIM PHYS MACROMOLECULAIRE   (France)

Author keywords

coronary heart disease; HDL; lipid profiling; lipidomics; lipoproteins; non HDL

Indexed keywords

ANTIHYPERTENSIVE AGENT; HIGH DENSITY LIPOPROTEIN; LINOLEIC ACID; LIPOPROTEIN; OMEGA 3 FATTY ACID; PHOSPHATIDYLCHOLINE; SATURATED FATTY ACID;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CLINICAL CHEMISTRY; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY OBSTRUCTION; DISEASE COURSE; FEMALE; HUMAN; LIPID ANALYSIS; LIPID COMPOSITION; LIPID METABOLISM; LIPIDOMICS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PATTERN RECOGNITION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; ATHEROSCLEROSIS; BLOOD; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX;

AGED; ATHEROSCLEROSIS; CORONARY DISEASE; CORONARY VESSELS; DISEASE PROGRESSION; FEMALE; HUMANS; LIPID METABOLISM; LIPOPROTEINS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; PROTON MAGNETIC RESONANCE SPECTROSCOPY; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 84899808813     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500061n     Document Type: Article

References (58)

1. Perk, J.; De Backer, G.; Gohlke, H.; Graham, I.; Reiner, Z.; Verschuren, M.; Albus, C.; Benlian, P.; Boysen, G.; Cifkova, R.; Deaton, C.; Ebrahim, S.; Fisher, M.; Germano, G.; Hobbs, R.; Hoes, A.; Karadeniz, S.; Mezzani, A.; Prescott, E.; Ryden, L.; Scherer, M.; Syvänne, M.; Scholte op Reimer, W. J.; Vrints, C.; Wood, D.; Zamorano, J. L.; Zannad, F.; European Association for Cardiovascular Prevention & Rehabilitation (EACPR); ESC Committee for Practice Guidelines (CPG) European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Eur. Heart J. 2012, 33, 1635-701
2. Melander, O.; Newton-Cheh, C.; Almgren, P.; Hedblad, B.; Berglund, G.; Engström, G.; Persson, M.; Smith, J. G.; Magnusson, M.; Christensson, A.; Struck, J.; Morgenthaler, N. G.; Bergmann, A.; Pencina, M. J.; Wang, T. J. Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community JAMA 2009, 302, 49-57
3. Barderas, M. G.; Laborde, C. M.; Posada, M.; de la Cuesta, F.; Zubiri, I.; Vivanco, F.; Alvarez-Llamas, G. Metabolomic Profiling for Identification of Novel Potential Biomarkers in Cardiovascular Diseases J. Biomed. Biotechnol. 2011, 2011, 790132
4. May, A.; Wang, T. J. Biomarkers for Cardiovascular Disease: Challenges and Future Directions Trends Mol. Med. 2008, 14, 261-267
5. Tavakol, M.; Ashraf, S.; Brener, S. J. Risks and Complications of Coronary Angiography: A Comprehensive Review Glob. J. Health Sci. 2012, 4, 65-93
6. Lewis, G. D.; Asnani, A.; Gerszten, R. E. Application of Metabolomics to Cardiovascular Biomarker and Pathway Discovery J. Am. Coll. Cardiol. 2008, 52, 117-123
7. Vasan, R. S. Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations Circulation. 2006, 113, 2335-2362
8. Lindon, J. C.; Holmes, E.; Bollard, M. E.; Stanley, E. G.; Nicholson, J. K. Metabonomics Technologies and Their Applications in Physiological Monitoring, Drug Safety Assessment and Disease Diagnosis Biomarkers. 2004, 9, 1-31
9. Parish, S.; Offer, A.; Clarke, R.; Hopewell, J. C.; Hill, M. R.; Otvos, J. D.; Armitage, J.; Collins, R.; on behalf of the Heart Protection Study Collaborative Group Lipids and Lipoproteins and Risk of Different Vascular Events in the MRC/BHF Heart Protection Study Circulation. 2012, 125, 2469-2478
10. Griffiths, W. J.; Ogundare, M.; Williams, C. M.; Wang, Y. On the Future of "Omics": Lipidomics J. Inherit. Metab. Dis. 2011, 34, 583-592
11. Giovane, A.; Balestrieri, A.; Napoli, C. New Insights into Cardiovascular and Lipid Metabolomics J. Cell Biochem. 2008, 105, 648-654
12. Ekroos, K.; Jänis, M.; Tarasov, K.; Hurme, R.; Laaksonen, R. Lipidomics: a Tool for Studies of Atherosclerosis Curr. Atheroscler. Rep. 2010, 12, 273-281
13. Kostara, C. E.; Papathanasiou, A.; Cung, M. T.; Elisaf, M. S.; Goudevenos, J.; Bairaktari, E. T. Evaluation of Established Coronary Heart Disease on the Basis of HDL and Non-HDL NMR Lipid Profiling J. Proteome Res. 2010, 9, 897-911
14. Nicholson, J. K.; Wilson, I. D. High Resolution Proton Magnetic Resonance Spectroscopy of Biological Fluids Prog. Nucl. Magn. Reson. Spec. 1989, 21, 449-501
15. Casu, M.; Anderson, G. J.; Choi, G.; Gibbons, W. A. NMR Lipid Profiles of Cells, Tissues and Body Fluids Magn. Reson. Chem. 1991, 29, 594-602
16. Tosi, M. R.; Trinchero, A.; Poerio, A.; Tugnoli, V. Fast NMR Evaluation of Lipids in Human Tissues Ital. J. Biochem. 2003, 52, 141-144
17. Rosenson, R. S. New Technologies Personalize Diagnostics and Therapeutics Curr. Atheroscler. Rep. 2010, 12, 184-186
18. Lindon, J. C.; Holmes, E.; Nicholson, J. K. Metabonomics and Its Role in Drug Development and Disease Diagnosis Expert. Rev. Mol. Diagn. 2004, 4, 189-199
19. Senn, T.; Hazen, S. L.; Tang, W. H. Translating Metabolomics to Cardiovascular Biomarkers Prog. Cardiovasc. Dis. 2012, 55, 70-76
20. Rhee, E. P.; Gerszten, R. E. Metabolomics and Cardiovascular Biomarker Discovery Clin. Chem. 2012, 58, 139-147
21. Grundy, S. M.; Pasternak, R.; Greenland, P.; Smith, S., Jr.; Fuster, V. Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations: A Statement for Healthcare Professionals from the American Heart Association and the American College of Cardiology Circulation 1999, 100, 1481-1492
22. Kostara, C. E.; Bairaktari, E. T. Lipid Profiling in Health and Disease. In Methodologies for Metabolomics: Experimental Strategies and Techniques; Lutz, M. W.; Sweedler, J. V.; Wevers, R. A., Eds.; Cambridge University Press: Cambridge, 2013; pp 317-332.
23. Bligh, E. G.; Dyer, W. J. A Rapid Method of Total Lipid Extraction and Purification Can. J. Biochem. Physiol. 1959, 37, 911-917
24. Eriksson, L.; Johansson, E.; Kettaneh-Wold, N.; Wold, S. Multi and Megavariate Data Analysis, Principles and Applications; Umetrics AB: Umea, Sweden, 2001.
25. Gavaghan, C. L.; Wilson, I. D.; Nicholson, J. K. Physiological Variation in Metabolic Phenotyping and Functional Genomic Studies: Use of Orthogonal Signal Correction and PLS-DA FEBS Lett. 2002, 530, 191-196
26. Bylesjö, M.; Rantalainen, M.; Cloarec, O.; Nicholson, J. K.; Holmes, E.; Trygg, J. OPLS Discriminant Analysis: Combining the Strengths of PLS-DA and SIMCA Classification J. Chemometrics. 2006, 20, 341-351
27. Vallejo, M.; García, A.; Tuñón, J.; García-Martínez, D.; Angulo, S.; Martin-Ventura, J. L.; Blanco-Colio, L. M.; Almeida, P.; Egido, J.; Barbas, C. Plasma Fingerprinting with GC-MS in Acute Coronary Syndrome Anal. Bioanal. Chem. 2009, 394, 1517-1524
28. Shah, S. H.; Sun, J. L.; Stevens, R. D.; Bain, J. R.; Muehlbauer, M. J.; Pieper, K. S.; Haynes, C.; Hauser, E. R.; Kraus, W. E.; Granger, C. B.; Newgard, C. B.; Califf, R. M.; Newby, L. K. Baseline Metabolomic Profiles Predict Cardiovascular Events in Patients at Risk for Coronary Artery Disease Am. Heart J. 2012, 163, 844-850
29. Brown, A. A.; Hu, F. B. Dietary Modulation of Endothelial Function: Implications for Cardiovascular Disease Am. J. Clin. Nutr. 2001, 73, 673-686
30. Phang, M.; Lazarus, S.; Wood, L. G.; Garg, M. Diet and Thrombosis Risk: Nutrients for Prevention of Thrombotic Disease Semin. Thromb. Hemost. 2011, 37, 199-208
31. Calder, P. C. Fatty Acids and Inflammation: The Cutting Edge between Food and Pharma Eur. J. Pharmacol. 2011, 668, S50-S58
32. Shen, J.; Johnson, V. M.; Sullivan, L. M.; Jacques, P. F.; Magnani, J. W.; Lubitz, S. A.; Pandey, S.; Levy, D.; Vasan, R. S.; Quatromoni, P. A.; Junyent, M.; Ordovas, J. M.; Benjamin, E. J. Dietary Factors and Incident Atrial Fibrillation: The Framingham Heart Study Am. J. Clin. Nutr. 2011, 93, 261-266
33. Brindle, J. T.; Antti, H.; Holmes, E.; Tranter, G.; Nicholson, J. K.; Bethell, H. W.; Clarke, S.; Schofield, P. M.; McKilligin, E.; Mosedale, D. E.; Grainger, D. J. Rapid and Noninvasive Diagnosis of the Presence and Severity of Coronary Heart Disease Using 1H-NMR-Based Metabonomics Nat. Med. 2002, 8, 1439-1444
34. Zheng, X.; Shen, J.; Liu, Q.; Wang, S.; Cheng, Y.; Qu, H. Plasma fatty Acids Metabolic Profiling Analysis of Coronary Heart Disease Based on GC-MS and Pattern Recognition J. Pharm. Biomed. Anal. 2009, 49, 481-486
35. Wang, L.; Folsom, A. R.; Eckfeldt, J. H. Plasma Fatty Acid Composition and Incidence of Coronary Heart Disease in Middle Aged Adults: The Atherosclerosis Risk in Communities (ARIC) Study Nutr. Metab. Cardiovasc. Dis. 2003, 13, 256-266
36. Brunner, H.; Cockcroft, J. R.; Deanfield, J.; Donald, A.; Ferrannini, E.; Halcox, J.; Kiowski, W.; Lüscher, T. F.; Mancia, G.; Natali, A.; Oliver, J. J.; Pessina, A. C.; Rizzoni, D.; Rossi, G. P.; Salvetti, A.; Spieker, L. E.; Taddei, S.; Webb, D. J. Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. Endothelial function and dysfunction. Part II: Association with Cardiovascular Risk Factors and Diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension J. Hypertens. 2005, 23, 233-246
37. Harvey, K. A.; Walker, C. L.; Pavlina, T. M.; Xu, Z.; Zaloga, G. P.; Siddiqui, R. A. Long-Chain Saturated Fatty Acids Induce Pro-Inflammatory Responses and Impact Endothelial Cell Growth Clin. Nutr. 2010, 29, 492-500
38. Marin, C.; Ramirez, R.; Delgado-Lista, J.; Yubero-Serrano, E. M.; Perez-Martinez, P.; Carracedo, J.; Garcia-Rios, A.; Rodriguez, F.; Gutierrez-Mariscal, F. M.; Gomez, P.; Perez-Jimenez, F.; Lopez-Miranda, J. Mediterranean Diet Reduces Endothelial Damage and Improves the Regenerative Capacity of Endothelium Am. J. Clin. Nutr. 2011, 93, 267-274
39. Ong, P. J.; Dean, T. S.; Hayward, C. S.; Della Monica, P. L.; Sanders, T. A.; Collins, P. Effect of Fat and Carbohydrate-e Consumption on Endothelial Function Lancet 1999, 354, 2134
40. Fuentes, F.; López-Miranda, J.; Sánchez, E.; Sánchez, F.; Paez, J.; Paz-Rojas, E.; Marín, C.; Gómez, P.; Jimenez-Perepérez, J.; Ordovás, J. M.; Pérez- Jiménez, F. Mediterranean and Low-Fat Diets Improve Endothelial Function in Hypercholesterolemic Men Ann. Int. Med. 2001, 134, 1115-1119
41. Spady, D. K.; Dietschy, J. M. Dietary Saturated Triacylglycerols Suppress Hepatic Low Density Lipoprotein Receptor Activity in the Hamster Proc. Natl. Acad. Sci. U.S.A. 1985, 82, 4526-4530
42. Dietschy, J. M. Dietary Fatty Acids and the Regulation of Plasma Low Density Lipoprotein Cholesterol Concentrations J. Nutr. 1998, 128, 444S-448S
43. Nicholls, S. J.; Lundman, P.; Harmer, J. A.; Cutri, B.; Griffiths, K. A.; Rye, K. A.; Barter, P. J.; Celermajer, D. S. Consumption of Saturated Fat Impairs the Anti-Inflammatory Properties of High-Density Lipoproteins and Endothelial Function J. Am. Coll. Cardiol. 2006, 48, 715-720
44. Pirillo, A.; Norata, G. D.; Catapano, A. L. Treating High Density Lipoprotein Cholesterol (HDL-C): Quantity Versus Quality Curr. Pharm. Des. 2013, 19, 3841-3857
45. Tsompanidi, E. M.; Brinkmeier, M. S.; Fotiadou, E. H.; Giakoumi, S. M.; Kypreos, K. E. HDL Biogenesis and Functions: Role of HDL Quality and Quantity in Atherosclerosis Atherosclerosis 2010, 208, 3-9
46. Sparks, D. L.; Davidson, W. S.; Lund-Katz, S.; Phillips, M. C. Effects of the Neutral Lipid Content of High Density Lipoprotein on Apolipoprotein A-I Structure and Particle Stability J. Biol. Chem. 1995, 270, 26910-26917
47. Maranhão, R. C.; Freitas, F. R.; Strunz, C. M.; Santos, R. D.; Mansur, A. J.; Mansur, A. P. Lipid Transfers to HDL Are Predictors of Precocious Clinical Coronary Heart Disease Clin. Chim. Acta 2012, 413, 502-505
48. Naito, H. K.; Greenstreet, R. L.; David, J. A.; Sheldon, W. L.; Shirey, E. K.; Lewis, R. C.; Proudfit, W. L.; Gerrity, R. G. HDL-Cholesterol Concentration and Severity of Coronary Atherosclerosis Determined by Cine-angiography Artery 1980, 8, 101-112
49. Kunz, F.; Pechlaner, C.; Erhart, R.; Fend, F.; Mühlberger, V. HDL and Plasma Phospholipids in Coronary Artery Disease Arterioscler. Thromb. 1994, 14, 1146-1150
50. Piperi, C.; Kalofoutis, C.; Papaevaggeliou, D.; Papapanagiotou, A.; Lekakis, J.; Kalofoutis, A. The Significance of Serum HDL Phospholipid Levels in Angiographically Defined Coronary Artery Disease Clin. Biochem. 2004, 37, 377-381
51. Horter, M. J.; Sondermann, S.; Reinecke, H.; Bogdanski, J.; Woltering, A.; Kerber, S.; Breithardt, G.; Assmann, G.; Von Eckardstein, A. Associations of HDL Phospholipids and Paraoxonase Activity with Coronary Heart Disease in Postmenopausal Women Acta. Physiol. Scand. 2002, 176, 123-130
52. Rye, K. A.; Duong, M. N. Influence of Phospholipid Depletion on the Size, Structure, And Remodeling of Reconstituted High Density Lipoproteins J. Lipid Res. 2000, 41, 1640-1650
53. Fournier, N.; de la Llera Moya, M.; Burkey, B. F.; Swaney, J. B.; Paterniti, J., Jr.; Moatti, N.; Atger, V.; Rothblat, G. H. Role of HDL Phospholipid in Efflux of Cell Cholesterol to Whole Serum: Studies with Human apoA-I Transgenic Rats J. Lipid Res. 1996, 37, 1704-1711
54. Rye, K. A.; Hime, N. J.; Barter, P. J. The Influence of Sphingomyelin on the Structure and Function of Reconstituted High Density Lipoproteins J. Biol. Chem. 1996, 271, 4243-4250
55. Baker, P. W.; Rye, K. A.; Gamble, J. R.; Vadas, M. A.; Barter, P. J. Phospholipid Composition of Reconstituted High Density Lipoproteins Influences Their Ability to Inhibit Endothelial Cell Adhesion Molecule Expression J. Lipid Res. 2000, 41, 1261-1267
56. Navab, M.; Hama, S.; Hough, G.; Fogelman, A. M. Oral Synthetic Phospholipid (DMPC) Raises High-Density Lipoprotein Cholesterol Levels, Improves High-Density Lipoprotein Function, And Markedly Reduces Atherosclerosis in Apolipoprotein E-null Mice Circulation. 2003, 108, 1735-1739
57. Rodrigueza, W. V.; Klimuk, S. K.; Pritchard, P. H.; Hope, M. J. Cholesterol Mobilization and Regression of Atheroma in Cholesterol-Fed Rabbits Induced by Large Unilamellar Vesicles Biochim. Biophys. Acta 1998, 1368, 306-320
58. Khera, A. V.; Cuchel, M.; de la Llera-Moya, M.; Rodrigues, A.; Burke, M. F.; Jafri, K.; French, B. C.; Phillips, J. A.; Mucksavage, M. L.; Wilensky, R. L.; Mohler, E. R.; Rothblat, G. H.; Rader, D. J. Cholesterol Efflux Capacity, High-Density Lipoprotein Function, And Atherosclerosis N. Engl. J. Med. 2011, 364, 127-135